Zendal Group
Press
Careers

You are on Vetia’s International website.

Go to Vetia Spain

DILPHES 4 Vacuna inactivada frente a la pasteurelosis en bovino, ovino y caprino

The packaging image may vary depending on the country in which it is marketed.

Logotipo CZ Vaccines
Manufacturer
CZ Vaccines, S.A.U
Medicinal product subject to veterinary prescription

DILPHES 4

Inactivated vaccine against pasteurellosis in cattle, sheep andgoats, in an injectable suspension
REQUEST MORE INFO
Target species
Cattle icon
Cattle
Sheep icon
Sheep
Goats icon
Goats
Composition per dose (2 ml)
Active substance:
Inactivated Pasteurella multocidainactivada, serotype A, strain NCTC 12177 and
Inactivated Pasteurella multocida serotype 6B, strain CECT 962 ≥104 DP50 *
Inactivated Mannheimia haemolytica, serotype A1, strain ATCC 33365 and
Inactivated Mannheimia haemolytica serotype A2, strain CECT 924 ≥41,08 UE**

*DP50: Protective dose 50% in mice.

**EU: Antibody titre in vaccinated sheep expressed in ELISA units.


Adjuvant:
Aluminium hydroxide (Al+3) 2,8 mg
Indications
Active immunisation to prevent infections caused by Pasteurella multocida and Mannheimia Poulthaemolytica.
  • Onset of immunity: 21 days.
Route of administration
Subcutaneous.
Dosage
Dose:
  • Cattle over 6 months of age: 5 ml.
  • Cattle under 6 months of age: 2 ml.
  • Sheep and goats from 2 months of age: 2 ml.
Vaccination schedule:
  • Primary vaccination: 2 doses. Separated by a 30-day interval.
    Pregnant females: Second dose 4–6 weeks before parturition.
 
  • Revaccination: 1 dose. Annual.
    Pregnant females: Administer before parturition.
Withdrawal period
Zero days.
DILPHES 4 Vacuna inactivada frente a la pasteurelosis en bovino, ovino y caprino

La imagen puede variar dependiendo del país en el que se comercialice.

Laboratorio fabricante
CZ Vaccines S.A.U.
Medicamento sujeto a prescripción veterinaria

DILPHES 4

Inactivated vaccine against pasteurellosis in cattle, sheep andgoats, in an injectable suspension
SOLICITE INFORMACIÓN
PREVENTING WITH EXPERTS
Composición por dosis (2 ml)
Active substance:
Inactivated Pasteurella multocidainactivada, serotype A, strain NCTC 12177 and
Inactivated Pasteurella multocida serotype 6B, strain CECT 962 ≥104 DP50 *
Inactivated Mannheimia haemolytica, serotype A1, strain ATCC 33365 and
Inactivated Mannheimia haemolytica serotype A2, strain CECT 924 ≥41,08 UE**

*DP50: Protective dose 50% in mice.

**EU: Antibody titre in vaccinated sheep expressed in ELISA units.


Adjuvant:
Aluminium hydroxide (Al+3) 2,8 mg
Indicaciones
Active immunisation to prevent infections caused by Pasteurella multocida and Mannheimia Poulthaemolytica.
  • Onset of immunity: 21 days.
Vía de administración
Subcutaneous.
Posología
Dose:
  • Cattle over 6 months of age: 5 ml.
  • Cattle under 6 months of age: 2 ml.
  • Sheep and goats from 2 months of age: 2 ml.
Pauta de vacunación
  • Primary vaccination: 2 doses. Separated by a 30-day interval.
    Pregnant females: Second dose 4–6 weeks before parturition.
 
  • Revaccination: 1 dose. Annual.
    Pregnant females: Administer before parturition.
Tiempo de espera
Zero days.
Scroll to Top